Galapagos NV
update 05/17
17.35
-0.13 (-0.74%%)
TODAY
High 17.85
Low 17.20
Open 17.51
Volume 187656
Time 05/17
52 WEEK SUMMARY
High 20.70
Low 10.50
P/E 0.00
Return
63.06%
Mkt Cap
514.69 M
Galapagos NV is a drug discovery company focused on the identification of disease modifying drug targets. The Company specializes in osteoporosis, rheumatoid arthritis, osteoarthritis and Alzheimer's disease.
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=509676875&utmp=%2Fquote%2FGLPG%3ABB%3Fcount%3D5&utmhn=10.248.67.14&utmac=UA-11413116-12&utmhid=677470607)